March 19, 2026

Lab Markers May Guide Lupus Biologic Use

Analysis of 31 trials links serologic activity and disease severity to improved response.

Conexiant

March 17, 2026

Obesity Medications Get New Guidance

Panel outlines pharmacotherapy roles across obesity complications and long-term weight management.

Conexiant

March 17, 2026

The Missing Step in Pediatric Lupus Care

Survey data show gaps between rheumatologists’ beliefs and clinical practice in screening and neuropsychological evaluation for childhood-onset systemic lupus erythematosus

Conexiant

March 16, 2026

Knee OA Trial Tests Diacerein

Researchers compared diacerein and placebo in a 24-week randomized study involving knee osteoarthritis with MRI-confirmed effusion-synovitis.

Conexiant

March 11, 2026

PCPs Unite to Strengthen Negotiating Power

Primary care practices are increasingly joining Independent Physician Associations to strengthen negotiating power with insurers and remain independent.

KFF Health News

March 09, 2026

​​​​​​​PsA Treatment Options Expand

Phase 3 POETYK trial results support FDA approval of deucravacitinib for adults with active PsA.

Conexiant

March 06, 2026

RA-ILD: Tracking Function and CT

Conventional monitoring markers do not change before deaths in this predominantly mild cohort.

Conexiant

March 04, 2026

Exercise in Osteoarthritis: Does It Help?

Overview data on exercise therapy in osteoarthritis question its universal promotion

Conexiant

February 25, 2026

Upadacitinib and Pain in RA, PsA

Mediation analysis suggests direct and indirect effects on pain reduction in rheumatoid and psoriatic arthritis.

Conexiant

February 24, 2026

Can CT Radiomics Detect Osteoporosis?

Radiomics analysis of lumbar spine computed tomography is compared with established imaging-based measures of bone density.

Conexiant